Facebook Instagram X-twitter Linkedin

IGF-DES (2mg)

Table of Contents

  • Quickstart Highlights

IGF-DES (2mg) protocols focus on this shortened analog of Insulin-like Growth Factor-1 (IGF-1 1-3), studied for its potential to enhance localized muscle growth, tissue repair, and post-exercise recovery. IGF-DES has a very short half-life and is often explored for targeted, site-specific applications. This guide outlines a subcutaneous or localized injection approach for the 2 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 2 mg/mL concentration
  • Typical range: 50–150 mcg per application (research-based use)
  • Easy measuring: At 2 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the IGF-DES regimen.

  • Goal: Support localized muscle repair and post-training recovery
  • Schedule: Often used around training sessions or targeted muscle groups
  • Dose Range: 50–150 mcg per application
  • Use Pattern: Typically applied peri-workout (before or after training)
  • Dosing Protocol

Suggested approach for the 2 mg vial format.

  • Start: 50 mcg per application to assess response
  • Target: 100–150 mcg per application, depending on goals
  • Frequency: 1–2 times daily or around training sessions
  • Vial Duration: One 2 mg vial can last approximately 10–40 applications, depending on dose
  • Timing: Commonly used pre-workout or post-workout for localized effect
  • Mechanism of Action

IGF-DES (Insulin-like Growth Factor-1 1-3) is a truncated form of IGF-1 that binds weakly to IGF-binding proteins, allowing it to act more rapidly and locally in tissues. Unlike full-length IGF-1, IGF-DES is designed for short, targeted activity at the injection site.

It is believed to activate IGF-1 receptors, promoting cellular uptake of amino acids, satellite cell activation, and protein synthesis in muscle tissue. This localized signaling may enhance muscle repair and hypertrophy responses, particularly when combined with resistance training. Due to its short half-life, effects are considered more immediate and site-specific compared to standard IGF-1.

  • Potential Benefits & Side Effects

Observations based on preclinical and limited research use.

Potential Benefits:

  • May support localized muscle growth and repair
  • May enhance post-exercise recovery
  • May improve nutrient uptake in targeted muscle tissue
  • May complement resistance training adaptations

Possible Side Effects:

  • Mild hypoglycemia-like symptoms (rare at low doses)
  • Temporary injection-site irritation
  • Headache or fatigue in some cases
  • Limited human safety data; remains investigational